Re-thinking dementia: A wellbeing approach
Join Dr Allen Power as he explains the limitations of an overly narrow biomedical view of dementia.
In this webinar, Dr Power will discusses why the BPSD paradigm is not only insufficient to address people’s needs, but actually creates a barrier to appropriate drug prescribing. At the same time, he will show how most non-pharmacological interventions and the research studies investigating them also fall short of success.
Dr G Allen PowerAllen is an internist, geriatrician, and Schlegel Chair in Aging and Dementia Innovation at the Schlegel-University of Waterloo Research Institute for Aging in Ontario, Canada. He is also clinical associate professor of medicine at the University of Rochester, NY, and an international educator on transformational models of care for older adults, particularly those living with changing cognitive abilities.
- Understand the demographics of psychotropic drug use and the risks of antipsychotic drugs
- Increase awareness regarding biomedical and transformational models of care and the benefits of focusing on wellbeing
- Improve knowledge and learn to understand other aids to communication